Company Filing History:
1 out of 832,912 Years Active: 2011
Title: Dmitri Lapotko: Innovator in Laser-Activated Nanothermolysis
Introduction
Dmitri Lapotko is a notable inventor based in Minsk, Belarus. He has made significant contributions to the field of biomedical engineering, particularly in the area of targeted cancer treatment. His innovative approach utilizes advanced technologies to enhance the effectiveness of therapies aimed at cancer cells.
Latest Patents
Dmitri Lapotko holds a patent for "Laser-activated nanothermolysis of cells." This patent describes methods and systems designed to increase selective thermomechanical damage to biological entities, such as cancer cells. The technology involves targeting cancer cells with nanoparticulates that contain specific targeting moieties. By applying pulsed electromagnetic radiation, the nanoparticulates are selectively heated, generating vapor microbubbles that damage the targeted cells while preserving surrounding healthy tissues. This method also includes a novel approach to treating leukemia.
Career Highlights
Throughout his career, Dmitri has focused on the intersection of nanotechnology and medicine. His work has been instrumental in developing techniques that improve the precision of cancer treatments. With a patent portfolio that includes innovative solutions, he continues to push the boundaries of what is possible in medical technology.
Collaborations
Dmitri Lapotko has collaborated with Alexander A Oraevsky, a fellow innovator in the field. Their partnership has fostered advancements in the application of laser technologies in medicine, particularly in cancer treatment.
Conclusion
Dmitri Lapotko's contributions to the field of biomedical engineering exemplify the potential of innovative technologies in improving cancer therapies. His work in laser-activated nanothermolysis represents a significant step forward in targeted treatment methods.